Olodaterol

(Striverdi Respimat®)

Olodaterol

Drug updated on 11/13/2023

Dosage FormInhalation spray (oral: 2.5 mcg)
Drug ClassLong-acting beta2-adrenergic agonist (LABA)
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • The long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.